Strides Pharma Correlations
| STAR Stock | 918.90 41.10 4.68% |
The current 90-days correlation between Strides Pharma Science and Sonata Software Limited is 0.23 (i.e., Modest diversification). The correlation of Strides Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Strides Pharma Correlation With Market
Average diversification
The correlation between Strides Pharma Science and DJI is 0.17 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Strides Pharma Science and DJI in the same portfolio, assuming nothing else is changed.
Strides |
The ability to find closely correlated positions to Strides Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Strides Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Strides Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Strides Pharma Science to buy it.
Moving together with Strides Stock
| 0.82 | VHL | Vardhman Holdings | PairCorr |
| 0.72 | BOSCHLTD | Bosch Limited | PairCorr |
| 0.82 | ABBOTINDIA | Abbott India Limited | PairCorr |
| 0.91 | FORCEMOT | FORCE MOTORS LTD Earnings Call This Week | PairCorr |
| 0.85 | HONAUT | Honeywell Automation | PairCorr |
| 0.93 | LLOYDSENT | Lloyds Enterprises | PairCorr |
| 0.85 | IDBI | IDBI Bank Limited | PairCorr |
Related Correlations Analysis
| -0.33 | -0.21 | -0.02 | 0.12 | -0.27 | 0.01 | -0.12 | SILVERTUC | ||
| -0.33 | 0.4 | 0.68 | 0.38 | 0.77 | 0.05 | 0.57 | RSSOFTWARE | ||
| -0.21 | 0.4 | 0.66 | 0.52 | 0.64 | -0.43 | 0.55 | SONATSOFTW | ||
| -0.02 | 0.68 | 0.66 | 0.75 | 0.81 | -0.3 | 0.71 | TATACOMM | ||
| 0.12 | 0.38 | 0.52 | 0.75 | 0.77 | -0.54 | 0.23 | STYRENIX | ||
| -0.27 | 0.77 | 0.64 | 0.81 | 0.77 | -0.34 | 0.44 | AXISILVER | ||
| 0.01 | 0.05 | -0.43 | -0.3 | -0.54 | -0.34 | 0.01 | SPECIALITY | ||
| -0.12 | 0.57 | 0.55 | 0.71 | 0.23 | 0.44 | 0.01 | KINGFA | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Strides Stock performing well and Strides Pharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Strides Pharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| SILVERTUC | 1.68 | (0.12) | (0.06) | 0.07 | 2.25 | 4.17 | 13.18 | |||
| RSSOFTWARE | 2.20 | 0.39 | 0.07 | 3.53 | 2.52 | 4.99 | 8.75 | |||
| SONATSOFTW | 1.81 | 0.35 | 0.12 | 0.73 | 1.91 | 7.25 | 18.76 | |||
| TATACOMM | 1.05 | 0.11 | (0.04) | 0.77 | 1.22 | 2.42 | 6.22 | |||
| STYRENIX | 1.22 | 0.11 | (0.05) | 0.84 | 1.05 | 3.08 | 10.02 | |||
| AXISILVER | 1.01 | 0.33 | 0.08 | (1.51) | 0.80 | 2.53 | 4.93 | |||
| SPECIALITY | 1.26 | (0.05) | 0.00 | (0.78) | 0.00 | 2.43 | 10.09 | |||
| KINGFA | 1.73 | 0.24 | 0.02 | 3.67 | 1.78 | 3.79 | 11.44 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Strides Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Earnings Calls Now
Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges |
| All Next | Launch Module |
Strides Pharma Corporate Management
Elected by the shareholders, the Strides Pharma's board of directors comprises two types of representatives: Strides Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Strides. The board's role is to monitor Strides Pharma's management team and ensure that shareholders' interests are well served. Strides Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Strides Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Manjula Ramamurthy | Compliance Secretary | Profile | |
| Christoph Funke | Chief Officer | Profile | |
| P Ramaraju | Chief Officer | Profile | |
| Lakshmi Narayanan | Chief Officer | Profile |